home / stock / virx / virx quote
Last: | $0.825 |
---|---|
Change Percent: | -1.01% |
Open: | $0.8293 |
Close: | $0.825 |
High: | $0.8392 |
Low: | $0.8076 |
Volume: | 56,518 |
Last Trade Date Time: | 05/09/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.825 | $0.8293 | $0.825 | $0.8392 | $0.8076 | 56,518 | 05-09-2024 |
$0.821 | $0.81 | $0.821 | $0.8397 | $0.81 | 26,818 | 05-08-2024 |
$0.82 | $0.83 | $0.82 | $0.84 | $0.8003 | 22,920 | 05-07-2024 |
$0.8001 | $0.8 | $0.8001 | $0.84 | $0.79 | 38,197 | 05-06-2024 |
$0.8102 | $0.8212 | $0.8102 | $0.84 | $0.8 | 33,087 | 05-03-2024 |
$0.84 | $0.82 | $0.84 | $0.8499 | $0.805 | 60,560 | 05-02-2024 |
$0.8201 | $0.8155 | $0.8201 | $0.884635 | $0.8 | 19,309 | 05-01-2024 |
$0.8196 | $0.85 | $0.8196 | $0.9 | $0.8093 | 40,753 | 04-30-2024 |
$0.821 | $0.81 | $0.821 | $0.86 | $0.81 | 84,450 | 04-29-2024 |
$0.8283 | $0.85 | $0.8283 | $0.85 | $0.8236 | 36,928 | 04-26-2024 |
$0.847 | $0.85 | $0.847 | $0.864 | $0.8201 | 37,828 | 04-25-2024 |
$0.8363 | $0.87 | $0.8363 | $0.9 | $0.83 | 55,053 | 04-24-2024 |
$0.8478 | $0.91 | $0.8478 | $0.91 | $0.76 | 83,651 | 04-23-2024 |
$0.88 | $0.85 | $0.88 | $0.899999 | $0.84 | 13,625 | 04-22-2024 |
$0.8567 | $0.8817 | $0.8567 | $0.91 | $0.8174 | 52,615 | 04-19-2024 |
$0.909 | $0.91 | $0.909 | $0.99 | $0.851001 | 79,490 | 04-18-2024 |
$0.93625 | $0.7374 | $0.93625 | $0.9499 | $0.7374 | 196,488 | 04-17-2024 |
$0.7148 | $0.773 | $0.7148 | $0.8199 | $0.67 | 256,597 | 04-16-2024 |
$0.78 | $1.03 | $0.78 | $1.04 | $0.76 | 606,565 | 04-15-2024 |
$1.15 | $1.3 | $1.15 | $1.31 | $1.084 | 339,011 | 04-12-2024 |
News, Short Squeeze, Breakout and More Instantly...
Viracta Therapeutics Inc. Company Name:
VIRX Stock Symbol:
NASDAQ Market:
Presented positive topline Nana-val results from Stage 1 of the pivotal Phase 2 NAVAL-1 trial in patients with relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV + ) peripheral T-cell lymphoma (PTCL) Initial results from the ongoing NAVAL-1 trial further validate ...
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (NASDAQ:VIRX), a clinical-stage precision oncology company focused on the...
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Travelers repo...